Neil Gallagher, President, Head of R&D: Syndax Pharmaceuticals SNDX Sell · Filed 25/02/12

Trade details

Type: Insider sale
Amount: $71,579
Shares · price: 4,618 sh · $15.50 a share
Held after: 85,095 sh
Stock: Syndax Pharmaceuticals SNDX
Person: Neil GallagherPresident, Head of R&D
Trade date: 25/02/10
Filed: 25/02/12
Days to filing: 2 days

Sold 5.1% of holdings

Share of holding sold: 5.1%

Syndax Pharmaceuticals trades, last 26 weeks

What else happened in Syndax Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/11~25/03/12

Neil Gallagher's recent trades

Neil GallagherFormer Director
Planned saleZymeworks
Planned sale
Zymeworks
ZYME
$2.5M
105,000 sh
$2.5M
Filed 25/11/21
Traded 25/11/21
Neil GallagherOfficer
Planned saleSyndax Pharmaceuticals
Planned sale
Syndax Pharmaceuticals
SNDX
$89.7K
9,679 sh
$89.7K
Filed 25/07/10
Traded 25/07/10
Neil GallagherOfficer
Planned saleSyndax Pharmaceuticals
Planned sale
Syndax Pharmaceuticals
SNDX
$71.6K
4,618 sh
$71.6K
Filed 25/02/10
Traded 25/02/10